To include your compound in the COVID-19 Resource Center, submit it here.

Portola sinks under AndexXa uncertainty

Portola Pharmaceuticals Inc. (NASDAQ:PTLA) dropped $10.76 (25%) to $31.56 Thursday, losing over $700 million in market cap, after it disclosed late Wednesday that FDA may require an additional

Read the full 284 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE